InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FGF | ACU/USDT .0124 worth more than FGF = .017AUD | 26/03/19 | 702 | 152K | |||
|
|||||||
FGF | Tokens, Crypto, Blockchain | 26/03/19 | 451 | 95K | |||
|
|||||||
FGF | Ann: FGF Secures 15% of E-Commerce Payment Business | 19/03/19 | 14 | 16K | |||
|
|||||||
FGF | Ann: YPB: 3.12m raised from Blockchain partners and equity | 14/03/19 | 74 | 17K | |||
|
|||||||
FGF | Ann: Update on Investment in Zyber | 11/03/19 | 0 | 535 | |||
|
|||||||
FGF | Ann: Half Year Financial Report - Amended | 07/03/19 | 10 | 2.1K | |||
|
|||||||
FGF | Ann: Twitter Investor Joins First Growth Advisory Board | 04/03/19 | 60 | 14K | |||
|
|||||||
FGF | Ann: Half Year Financial Report | 01/03/19 | 1 | 373 | |||
|
See All Discussions